Loss of the type Ill TGF-β receptor during cancer progression generates an immunotolerant tumor microenvironment: Translational implications for TGF-β inhibition and immunotherapy biomarker development

被引：0
|
作者：
Hanks, Brent A. [1 ]
Holtzhausen, Alisha [1 ]
Gimpel, Petra [2 ]
Campbell, Olivia [1 ]
Jamieson, Rebekah [1 ]
Ling, Leona E. [3 ]
Morse, Michael A. [1 ]
Lyerly, H. K. [1 ]
Blobe, Gerard [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Berlin, Berlin, Germany
[3] Biogen Idec Inc, Cambridge, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3548
引用
收藏
页数：1
相关论文
共 47 条
  • [31] Eribulin impairs the transport of TGF-13 type I receptor leading to inhibition of downstream non-canonical TGF-β signaling necessary for cancer metastasis and survival
    Rohena, C. C.
    Kaul, R.
    Risinger, A. L.
    Mooberry, S. L.
    CANCER RESEARCH, 2016, 76
  • [32] Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti-tumor immunotherapy
    Wang, Yang
    Gao, Zhuxin
    Du, Xiaojiao
    Chen, Senbiao
    Zhang, Wangcheng
    Wang, Jilong
    Li, Hongjun
    He, Xinyu
    Cao, Jie
    Wang, Jun
    BIOMATERIALS SCIENCE, 2020, 8 (18) : 5121 - 5132
  • [33] Progression of Human Bronchioloalveolar Carcinoma to Invasive Adenocarcinoma Is Modeled in a Transgenic Mouse Model of K-ras-Induced Lung Cancer by Loss of the TGF-β Type II Receptor
    Borczuk, Alain C.
    Sole, Marieta
    Lu, Ping
    Chen, Jinli
    Wilgus, May-Lin
    Friedman, Richard A.
    Albelda, Steven M.
    Powell, Charles A.
    CANCER RESEARCH, 2011, 71 (21) : 6665 - 6675
  • [34] Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor
    Fanayan, S
    Firth, SM
    Butt, AJ
    Baxter, RC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39146 - 39151
  • [35] Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma
    Yeung, Oscar Wai Ho
    Qi, Xiang
    Pang, Li
    Liu, Hui
    Ng, Kevin Tak Pan
    Liu, Jiang
    Lo, Chung Mau
    Man, Kwan
    CANCERS, 2021, 13 (07)
  • [36] Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell model
    Lee, Song-Yi
    Byeon, Seonggyu
    Ko, Jihoon
    Hyung, Sujin
    Lee, In-Kyoung
    Li Jeon, Noo
    Hong, Jung Yong
    Kim, Seung Tae
    Park, Se Hoon
    Lee, Jeeyun
    CANCER MEDICINE, 2021, 10 (20): : 7253 - 7262
  • [37] An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition
    Park, Chul-Yong
    Min, Kyung Nan
    Son, Jee-Yeon
    Park, So-Yeon
    Nam, Jeong-Seok
    Kim, Dae-Kee
    Sheen, Yhun Yhong
    CANCER LETTERS, 2014, 351 (01) : 72 - 80
  • [38] Chimeric cytokine receptor TGF-β RII/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
    Ren, Yaojun
    Xue, Min
    Hui, Xinhui
    Liu, Xiuyu
    Farooq, Muhammad Asad
    Chen, Yiran
    Ji, Yuzhou
    Duan, Yixin
    Ajmal, Iqra
    Yao, Jie
    Jiang, Wenzheng
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [39] KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
    A Ali
    P Zhang
    Y Liangfang
    S Wenshe
    H Wang
    X Lin
    Y Dai
    X-h Feng
    R Moses
    D Wang
    X Li
    J Xiao
    Cell Death & Disease, 2015, 6 : e1681 - e1681
  • [40] KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
    Ali, A.
    Zhang, P.
    Liangfang, Y.
    Wenshe, S.
    Wang, H.
    Lin, X.
    Dai, Y.
    Feng, X-H
    Moses, R.
    Wang, D.
    Li, X.
    Xiao, J.
    CELL DEATH & DISEASE, 2015, 6 : e1681 - e1681
12345